产品详情 |
Edit |   |
Product Name | L929/A |
Description | This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resistance can be circumvented by modulating agents such as verapamil and quinine. The parent cell line L929 was derived from normal subcutaneous areolar adipose tissue. |
Size | n/a |
Concentration | n/a |
Applications | n/a |
Other Names | n/a |
Gene, Accession, CAS # | n/a |
Catalog # | CSC-C9505J |
Price | |
Order / More Info | L929/A from CREATIVE BIOARRAY |
Product Specific References | n/a |
产品资料 |
|
|